Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
about
Retargeting Strategies for Oncolytic Herpes Simplex VirusesRestored in vivo-like membrane lipidomics positively influence in vitro features of cultured mesenchymal stromal/stem cells derived from human placentaA Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.Retargeting of herpes simplex virus (HSV) vectors.Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer CellsStem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumorsHSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic VirusesMesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Q26765439-E8B08AA2-8EBF-4095-A2AE-9F95EA4DA9E8Q37631015-46B4BA98-7E8B-46D7-B46A-B8CDA6A88F29Q38714321-AF578ABE-D79D-417F-9811-EEE0243B06A8Q38950892-CEB1BAAA-B16F-4F37-810C-14B051D1DC4DQ39339386-AA8E7D7A-31F5-4454-A580-FFCA2306105CQ40122051-1962685A-AAD8-4CC1-9495-94275E9B79A8Q40310537-642D5091-AC87-47DC-91C0-ACA61EF43113Q47562626-C294960B-D14B-4BC9-A4BE-79B78D735AF8Q47562637-923C5F3F-C226-443F-993C-63BF339D3282Q52653941-69ADC6D7-01A2-4DB6-AE0B-33538313C202Q56348401-D69D6D83-56A7-447D-A6E2-5F88F9D7394EQ56378150-44EA4285-9B81-4496-BDF5-368EB6E5FFB4Q57174410-1627E068-00C6-4163-A6A9-B8EB529452F2
P2860
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@ast
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@en
type
label
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@ast
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@en
prefLabel
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@ast
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@en
P2093
P2860
P50
P356
P1433
P1476
Systemic delivery of HER2-reta ...... rom lung and brain metastases.
@en
P2093
Arianna Palladini
Dario Ranieri
Francesco Alviano
Giordano Nicoletti
Laura Bonsi
Martina Rossi
Patrizia Nanni
Valentina Grosso
P2860
P304
34774-34787
P356
10.18632/ONCOTARGET.5793
P407
P50
P577
2015-09-27T00:00:00Z